Charles Schwab Corporation
SCHW
$92.03
+0.36%
The Charles Schwab Corporation is a leading US financial services company operating across retail brokerage, banking, asset management, custody, and wealth management, with $11.9 trillion in client assets. It is a dominant market leader, particularly in Registered Investment Advisor (RIA) custody where it holds over 40% market share, and has expanded its competitive identity through wealth management solutions like robo-advisory and direct indexing. The current investor narrative is shaped by the stock's significant underperformance relative to the broader market in 2026, as it grapples with sector-wide pressures from shifting interest rate expectations and competitive dynamics, while recent news highlights ongoing analyst scrutiny of its valuation and growth prospects.…
SCHW
Charles Schwab Corporation
$92.03
Related headlines
SCHW 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Charles Schwab Corporation's 12-month outlook, with a consensus price target around $119.64 and implied upside of +30.0% versus the current price.
Average Target
$119.64
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$74 - $120
Analyst target range
Analyst coverage for Schwab is substantial, with data showing at least six major firms providing ratings, and recent institutional actions from firms like Barclays, UBS, and TD Cowen maintaining 'Overweight' or 'Buy' stances as recently as January 2026. The consensus sentiment leans bullish, as evidenced by the reiterated buy ratings, though the average target price and implied upside cannot be precisely calculated from the provided data which lacks a specific consensus target; the estimated EPS average for the forward period is $10.10, with a range from $9.18 to $10.55, indicating analyst confidence in sustained profitability. The target price range and signal strength cannot be quantified without explicit high/low price targets, but the wide estimated EPS range (a spread of about 13% from low to high) suggests some degree of uncertainty in near-term earnings forecasts. The pattern of recent ratings shows stability, with no downgrades in the provided sample from January 2026, indicating analyst conviction has held steady despite the stock's price weakness; however, the absence of more recent ratings post-January 2026, coupled with the stock's subsequent decline, may imply targets are under review or that the current price fall has outpaced analyst expectations.
SCHW Technical Analysis
The stock is in a pronounced downtrend, having declined 9.72% year-to-date and 7.21% over the last six months, starkly underperforming the S&P 500 which gained 9.51% and 9.72% over the same periods, respectively. With a current price near $91.70, it is trading approximately 15% below its 52-week high of $107.5 and about 9% above its 52-week low of $83.96, positioning it in the lower quartile of its annual range which signals significant selling pressure and potential value opportunity, though the persistent downtrend suggests it may be a 'falling knife' scenario. Recent momentum is deeply negative, with the stock down 11.98% over the past month and 3.13% over the past three months, a clear acceleration of the longer-term downtrend as evidenced by its severe negative relative strength of -18.27% and -22.99% against the S&P 500 over 3-month and 1-year periods; this divergence from the market's strong rally indicates company or sector-specific headwinds overwhelming any broader bullish sentiment. Key technical support is at the 52-week low of $83.96, while resistance is at the 52-week high of $107.5; a breakdown below $83.96 would signal a new leg down and likely trigger further selling, whereas a sustained move above the recent downtrend channel would be needed to suggest a reversal. The stock's beta of 0.77 indicates it is 23% less volatile than the market, which is unusual for a financial stock but may reflect its large-cap, diversified nature; however, its high maximum drawdown of -20.39% shows it has experienced significant peak-to-trough losses, demanding careful risk management despite the lower beta.
Beta
0.77
0.77x market volatility
Max Drawdown
-20.4%
Largest decline past year
52-Week Range
$84-$108
Price range past year
Annual Return
+3.2%
Cumulative gain past year
| Period | SCHW Return | S&P 500 |
|---|---|---|
| 1m | +2.1% | -0.2% |
| 3m | -3.8% | +14.0% |
| 6m | -9.6% | +7.8% |
| 1y | +3.2% | +25.3% |
| ytd | -9.4% | +9.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SCHW Fundamental Analysis
Revenue growth is positive but has shown signs of deceleration; Q4 2025 revenue was $7.17 billion, representing a 7.8% year-over-year increase, yet this marks a slowdown from the stronger sequential growth seen in Q3 ($7.04 billion) and Q2 ($6.82 billion). The revenue segment data reveals a bifurcated business: Investor Services generated $9.92 billion, while Advisor Services contributed $2.55 billion, indicating the core retail brokerage and banking operations are the primary growth engine, though the overall multi-quarter trend suggests growth momentum is moderating. The company is highly profitable, with Q4 2025 net income of $2.46 billion and a robust net margin of 34.3%, reflecting strong earnings power. Gross margin was exceptionally high at 86.4% for the quarter, and operating margin stood at 41.4%, levels that are superior to typical financial services firms due to its asset-light, fee-based model; margins have expanded significantly from the year-ago period (Q4 2024 net margin of 27.7%), demonstrating impressive operating leverage and efficiency gains. The balance sheet and cash flow position is mixed, characterized by strong profitability metrics but volatile cash generation; the debt-to-equity ratio is a conservative 0.63, indicating a low reliance on debt financing, and Return on Equity (ROE) is a healthy 17.9%. However, trailing twelve-month free cash flow is a substantial $8.76 billion, but quarterly operating cash flow has been erratic, turning negative in Q4 2025 at -$763 million; the current ratio of 0.53 suggests limited short-term liquidity, which is typical for banks and brokerages that fund operations with client assets rather than corporate cash, but the strong FCF yield supports shareholder returns and internal reinvestment.
Quarterly Revenue
$7.2B
2025-12
Revenue YoY Growth
+0.07%
YoY Comparison
Gross Margin
+0.81%
Latest Quarter
Free Cash Flow
$8.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SCHW Overvalued?
Given Net Income of $2.46 billion is positive, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 20.0x, while the forward PE is notably lower at 12.6x, implying the market expects significant earnings growth or a normalization of profitability in the coming year; the PEG ratio of 0.36, based on this forward multiple, suggests the stock is deeply undervalued relative to its growth prospects if those estimates are accurate. Compared to industry averages, Schwab trades at a premium on a Price-to-Sales basis (PS ratio of 6.40x) but the more relevant PE comparison shows its forward multiple of 12.6x is likely in line with or at a discount to large-cap financial peers, though specific industry average data is not provided in the valuation set; the premium on sales reflects its high net margin profile, which at 32.0% justifies a higher sales multiple than lower-margin competitors. Historically, the stock's own valuation has compressed significantly; its current trailing PE of 20.0x is below the historical high observed in recent quarters (e.g., 25.2x in Q2 2024) and is approaching the lower end of its range seen over the past few years (e.g., 14.98x in Q1 2023). Trading near the bottom of its own historical PE band suggests the market is pricing in pessimistic expectations, potentially offering a value opportunity if the company's fundamentals remain intact, but it could also indicate perceived fundamental deterioration given the sharp price decline.
PE
21.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 15x~30x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.6x
Enterprise Value Multiple

